Phase 4 Crohn Disease Clinical Trials
15 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–15 of 15 trials
Recruiting
Phase 4
Combined Immunosuppression for Pediatric Crohn's Disease
Crohn DiseaseImmunosuppressionChildren, Only+1 more
Children's Hospital of Fudan University128 enrolled1 locationNCT05043870
Recruiting
Phase 4
A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
Crohn Disease
Xian-Janssen Pharmaceutical Ltd.78 enrolled4 locationsNCT07310095
Recruiting
Phase 4
Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease
Crohn Disease
Sixth Affiliated Hospital, Sun Yat-sen University214 enrolled1 locationNCT06520397
Recruiting
Phase 4
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Crohn DiseaseDisease CrohnModerately to Severely Active Crohn's Disease
Alimentiv Inc.304 enrolled69 locationsNCT06257706
Recruiting
Phase 4
De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis
Ulcerative Colitis (UC)Crohn Disease (CD)
McGill University Health Centre/Research Institute of the McGill University Health Centre115 enrolled1 locationNCT07303686
Recruiting
Phase 4
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Crohn Disease
Connecticut Children's Medical Center900 enrolled26 locationsNCT05781152
Recruiting
Phase 4
PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease
Crohn Disease
University of Calgary297 enrolled20 locationsNCT05928039
Recruiting
Phase 4
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Crohn Disease
Taizhou Mabtech Pharmaceutical Co.,Ltd30 enrolled1 locationNCT05906576
Recruiting
Phase 4
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
Crohn Disease
University of Miami24 enrolled1 locationNCT06774079
Recruiting
Phase 4
Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.
Crohn DiseaseUlcerative Colitis
University of Manitoba418 enrolled1 locationNCT06298461
Recruiting
Phase 4
Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy
Crohn Disease
Universitaire Ziekenhuizen KU Leuven292 enrolled28 locationsNCT05169593
Recruiting
Phase 4
Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease
Crohn DiseaseChild, OnlyBiologic; Inadequate
Erasmus Medical Center50 enrolled1 locationNCT05552287
Recruiting
Phase 4
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW275 enrolled15 locationsNCT06113913
Recruiting
Phase 4
TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
Crohn DiseasePerianal Fistula Due to Crohn's DiseaseInfliximab+2 more
Asan Medical Center86 enrolled1 locationNCT06051253
Recruiting
Phase 4
Control Crohn Safe Trial
Inflammatory Bowel DiseasesCrohn Disease
Maastricht University Medical Center158 enrolled6 locationsNCT03917303